LENSAR INC (LNSR) Stock Fundamental Analysis

USA Nasdaq NASDAQ:LNSR • US52634L1089

12.1 USD
+0.02 (+0.17%)
Last: Feb 9, 2026, 10:44 AM
Fundamental Rating

2

LNSR gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of LNSR have multiple concerns. LNSR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year LNSR has reported negative net income.
  • LNSR had a negative operating cash flow in the past year.
  • LNSR had negative earnings in each of the past 5 years.
  • In the past 5 years LNSR always reported negative operating cash flow.
LNSR Yearly Net Income VS EBIT VS OCF VS FCFLNSR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • With a Return On Assets value of -73.39%, LNSR is not doing good in the industry: 73.66% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -73.39%
ROE N/A
ROIC N/A
ROA(3y)-34.59%
ROA(5y)-31.65%
ROE(3y)-81.1%
ROE(5y)-61.69%
ROIC(3y)N/A
ROIC(5y)N/A
LNSR Yearly ROA, ROE, ROICLNSR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1.3 Margins

  • LNSR has a Gross Margin (46.15%) which is in line with its industry peers.
  • In the last couple of years the Gross Margin of LNSR has grown nicely.
  • LNSR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 46.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.25%
GM growth 5Y2.2%
LNSR Yearly Profit, Operating, Gross MarginsLNSR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

1

2. Health

2.1 Basic Checks

  • LNSR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for LNSR has been increased compared to 1 year ago.
  • Compared to 5 years ago, LNSR has more shares outstanding
  • LNSR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LNSR Yearly Shares OutstandingLNSR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
LNSR Yearly Total Debt VS Total AssetsLNSR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -2.45, we must say that LNSR is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -2.45, LNSR is doing worse than 61.29% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.45
ROIC/WACCN/A
WACC9.78%
LNSR Yearly LT Debt VS Equity VS FCFLNSR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

  • LNSR has a Current Ratio of 1.24. This is a normal value and indicates that LNSR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of LNSR (1.24) is worse than 80.11% of its industry peers.
  • A Quick Ratio of 0.67 indicates that LNSR may have some problems paying its short term obligations.
  • LNSR's Quick ratio of 0.67 is on the low side compared to the rest of the industry. LNSR is outperformed by 87.63% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.67
LNSR Yearly Current Assets VS Current LiabilitesLNSR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

6

3. Growth

3.1 Past

  • LNSR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -200.68%.
  • The Revenue has grown by 21.02% in the past year. This is a very strong growth!
  • The Revenue has been growing by 11.87% on average over the past years. This is quite good.
EPS 1Y (TTM)-200.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.46%
Revenue 1Y (TTM)21.02%
Revenue growth 3Y15.79%
Revenue growth 5Y11.87%
Sales Q2Q%5.74%

3.2 Future

  • LNSR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 29.14% yearly.
  • LNSR is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 29.01% yearly.
EPS Next Y-5.37%
EPS Next 2Y41.42%
EPS Next 3Y29.14%
EPS Next 5YN/A
Revenue Next Year21.28%
Revenue Next 2Y28.37%
Revenue Next 3Y29.01%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LNSR Yearly Revenue VS EstimatesLNSR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
LNSR Yearly EPS VS EstimatesLNSR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2027 0 -2 -4 -6 -8

1

4. Valuation

4.1 Price/Earnings Ratio

  • LNSR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
LNSR Price Earnings VS Forward Price EarningsLNSR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
LNSR Per share dataLNSR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as LNSR's earnings are expected to grow with 29.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y29.14%

0

5. Dividend

5.1 Amount

  • No dividends for LNSR!.
Industry RankSector Rank
Dividend Yield 0%

LENSAR INC

NASDAQ:LNSR (2/9/2026, 10:44:17 AM)

12.1

+0.02 (+0.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-25
Inst Owners49.71%
Inst Owner Change-0.6%
Ins Owners19.38%
Ins Owner Change-0.15%
Market Cap144.47M
Revenue(TTM)59.14M
Net Income(TTM)-51.52M
Analysts45.71
Price Target15.3 (26.45%)
Short Float %7.87%
Short Ratio18.7
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-301.96%
Min EPS beat(2)-507.84%
Max EPS beat(2)-96.08%
EPS beat(4)0
Avg EPS beat(4)-687.06%
Min EPS beat(4)-1367.43%
Max EPS beat(4)-96.08%
EPS beat(8)2
Avg EPS beat(8)-359.42%
EPS beat(12)4
Avg EPS beat(12)-250.66%
EPS beat(16)8
Avg EPS beat(16)-183.01%
Revenue beat(2)0
Avg Revenue beat(2)-18.62%
Min Revenue beat(2)-19.8%
Max Revenue beat(2)-17.45%
Revenue beat(4)2
Avg Revenue beat(4)-5.89%
Min Revenue beat(4)-19.8%
Max Revenue beat(4)10.09%
Revenue beat(8)4
Avg Revenue beat(8)-1.11%
Revenue beat(12)6
Avg Revenue beat(12)-0.65%
Revenue beat(16)8
Avg Revenue beat(16)0.36%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-940.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.46%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-8.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.44
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.39
EYN/A
EPS(NY)0
Fwd EYN/A
FCF(TTM)-0.99
FCFYN/A
OCF(TTM)-0.99
OCFYN/A
SpS4.95
BVpS-1.02
TBVpS-1.47
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.39%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 46.15%
FCFM N/A
ROA(3y)-34.59%
ROA(5y)-31.65%
ROE(3y)-81.1%
ROE(5y)-61.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.25%
GM growth 5Y2.2%
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.94%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.67
Altman-Z -2.45
F-Score3
WACC9.78%
ROIC/WACCN/A
Cap/Depr(3y)4.73%
Cap/Depr(5y)8.26%
Cap/Sales(3y)0.4%
Cap/Sales(5y)0.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-200.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-138.46%
EPS Next Y-5.37%
EPS Next 2Y41.42%
EPS Next 3Y29.14%
EPS Next 5YN/A
Revenue 1Y (TTM)21.02%
Revenue growth 3Y15.79%
Revenue growth 5Y11.87%
Sales Q2Q%5.74%
Revenue Next Year21.28%
Revenue Next 2Y28.37%
Revenue Next 3Y29.01%
Revenue Next 5YN/A
EBIT growth 1Y-143.4%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year86.09%
EBIT Next 3Y40.8%
EBIT Next 5YN/A
FCF growth 1Y16.29%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y15.41%
OCF growth 3YN/A
OCF growth 5YN/A

LENSAR INC / LNSR FAQ

What is the ChartMill fundamental rating of LENSAR INC (LNSR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to LNSR.


Can you provide the valuation status for LENSAR INC?

ChartMill assigns a valuation rating of 1 / 10 to LENSAR INC (LNSR). This can be considered as Overvalued.


How profitable is LENSAR INC (LNSR) stock?

LENSAR INC (LNSR) has a profitability rating of 1 / 10.


What is the expected EPS growth for LENSAR INC (LNSR) stock?

The Earnings per Share (EPS) of LENSAR INC (LNSR) is expected to decline by -5.37% in the next year.